Table of Contents Table of Contents
Previous Page  35 / 91 Next Page
Information
Show Menu
Previous Page 35 / 91 Next Page
Page Background

34

29

th

CONGRESS OF THE ESPU

08:52–09:34

S5: VESICOURETERAL REFLUX 2

Moderators: Goedele Beckers (Netherlands), Alexander Springer (Austria)

08:52–08:55

S5-1 (PP)

POSTNATAL IMAGING OF PRENATALLY DETECTED HYRONEPHROSIS–WHEN IS VOIDING

CYSTOURETHROGRAM NECESSARY?

Sofia VISURI 

1

, Reetta KIVISAARI 

2

, Timo JAHNUKAINEN 

3

and Seppo TASKINEN 

1

1 Helsinki University Hospital, Department of Pediatric surgery, Helsinki, FINLAND

2 Helsinki University Hospital, Department of Pediatric Radiology, Helsinki, FINLAND

3 Helsinki University Hospital, Department of Pediatric Nephrology and Transplantation, Helsinki, FINLAND

08:55–08:58

S5-2 (PP)

DIAGNOSTIC ACCURACY OF VOIDING DYSFUNCTION PATTERNS AS A PREDICTIVE TOOL OF VESICOURETERAL

REFLUX RESOLUTION AFTER FIRST ENDOSCOPIC TREATMENT

José A MARCH, Agustín SERRANO-DURBÁ, Alba POLO, Povo IVAN, Mari Angeles CONCA and Carlos DOMÍNGUEZ

La Fe Universitarian Hospital, Pediatric Urology Unit,Valencia, SPAIN

08:58–09:01

S5-3 (PP)

FOOT PRINT SIGN: COULD VOIDING CYSTOURETHROGRAPHY DISCOVER POOR RENAL FUNCTION

IN VESICOURETERAL REFLUX?

Mehrnoosh SAMAEI 

1

, Sahar EFTEKHARZADEH 

1

, Ehsan SADEGHIAN 

1

, Mehrzad MEHDIZADEH 

1

and Abdol-Mohammad KAJBAFZADEH 

2

1 Children’s Hospital Medical Center, Tehran University of Medical Sciences, Pediatric Urology Research Center, Tehran, (ISLAMIC REPUBLIC

OF IRAN)

2 Children’s Hospital, Urology, Tehran, (ISLAMIC REPUBLIC OF IRAN)

09:01–09:04

S5-4 (PP)

DID OUR CURRENT INITIAL TREATMENT PRACTICE CHANGE AFTER EAU/ESPU VESICOURETERAL REFLUX

RISK GROUPING?

Eda TOKAT 

1

, Serhat GUROCAK 

1

, Iyimser URE 

2

, Cenk ACAR 

3

, Zafer SINIK 

4

and Ozgur TAN 

1

1 Gazi University School of Medicine, Department of Urology, Section of Paediatric Urology, Ankara, TURKEY

2 Eskisehir Osmangazi University School of Medicine, Department of Urology, Eskisehir, TURKEY

3 Eryaman Hospital, Department of Urology, Ankara, TURKEY

4 Odak Hospital, Department of Urology, Denizli, TURKEY

09:01–09:04

S5-5 (PP)

[PRESENTATION GROUPED WITH PREVIOUS] HOW DID OUR TREATMENTS BEFORE AND AFTER EAU/ESPU

VUR RISK GROUPING SYSTEM AFFECT OUR EARLY SUCCESS RATES?

Eda TOKAT 

1

, Serhat GUROCAK 

1

, Iyimser URE 

2

, Cenk ACAR 

3

, Zafer SINIK 

4

and Ozgur TAN 

1

1 Gazi University School of Medicine, Department of Urology, Section of Paediatric Urology, Ankara, TURKEY

2 Eskisehir Osmangazi University School Of Medicine, Department of Urology, Eskisehir, TURKEY

3 Eryaman Hospital, Department of Urology, Ankara, TURKEY

4 Odak Hospital, Department of Urology, Denizli, TURKEY